{"id":137815,"date":"2026-07-01T17:45:53","date_gmt":"2026-07-01T12:15:53","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=137815"},"modified":"2026-07-01T17:45:54","modified_gmt":"2026-07-01T12:15:54","slug":"nifty-pharma-prediction-for-tomorrow-2-july-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/","title":{"rendered":"Nifty Pharma Prediction for Tomorrow 2 July 2026: Key Levels and Sector Outlook"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Nifty Pharma at 25,182.70 (-0.57%) on 1 July. Dr Reddy&#8217;s -1.35%, Sun Pharma -0.66%. Cipla +0.78% shows relative strength. Support 25,100. Resistance 25,450.<\/em><\/p>\n<p>The <strong>Nifty Pharma prediction for tomorrow<\/strong> 2 July 2026 is cautiously bearish as the index closed Wednesday 1 July at <strong>25,182.70 (-0.57%)<\/strong>, with Dr Reddy&#8217;s Laboratories declining 1.35% to Rs 1,357.10 and Sun Pharma falling 0.66% to Rs 1,862.50. The <strong>Nifty Pharma prediction for tomorrow<\/strong> is partially cushioned by Cipla&#8217;s 0.78% gain to Rs 1,465.40 \u2014 showing domestic business resilience over US export-focused peers. The session range was 25,133.25 to 25,591.30. Nifty Pharma<\/p>\n<p>Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, present the analysis for the <strong>Nifty Pharma prediction for tomorrow<\/strong> 2 July 2026.<\/p>\n<p><strong>Click Here \u2013 Get Free Investment Predictions<\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#Market_Recap_Wednesday_1_July_2026\" title=\"Market Recap: Wednesday 1 July 2026\">Market Recap: Wednesday 1 July 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#Nifty_Pharma_Nifty_Pharma_Prediction_For_Tomorrow_%E2%80%94_Technical_Levels\" title=\"Nifty Pharma: Nifty Pharma Prediction For Tomorrow \u2014 Technical Levels\">Nifty Pharma: Nifty Pharma Prediction For Tomorrow \u2014 Technical Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#Global_Cues_Affecting_the_Nifty_Pharma_Prediction_For_Tomorrow\" title=\"Global Cues Affecting the Nifty Pharma Prediction For Tomorrow\">Global Cues Affecting the Nifty Pharma Prediction For Tomorrow<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#Stocks_Driving_the_Nifty_Pharma_Prediction_for_Tomorrow\" title=\"Stocks Driving the Nifty Pharma Prediction for Tomorrow\">Stocks Driving the Nifty Pharma Prediction for Tomorrow<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#Trading_Strategy_for_the_Nifty_Pharma_Prediction_For_Tomorrow\" title=\"Trading Strategy for the Nifty Pharma Prediction For Tomorrow\">Trading Strategy for the Nifty Pharma Prediction For Tomorrow<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#F_O_and_Options_Data_for_the_Nifty_Pharma_Prediction_For_Tomorrow\" title=\"F&amp;O and Options Data for the Nifty Pharma Prediction For Tomorrow\">F&amp;O and Options Data for the Nifty Pharma Prediction For Tomorrow<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#GIFT_Nifty_Signal_for_Thursday_2_July_2026\" title=\"GIFT Nifty Signal for Thursday 2 July 2026\">GIFT Nifty Signal for Thursday 2 July 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#Stocks_to_Watch_for_the_Nifty_Pharma_Prediction_For_Tomorrow\" title=\"Stocks to Watch for the Nifty Pharma Prediction For Tomorrow\">Stocks to Watch for the Nifty Pharma Prediction For Tomorrow<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#Key_Terminology_Nifty_Pharma_Prediction_For_Tomorrow\" title=\"Key Terminology: Nifty Pharma Prediction For Tomorrow\">Key Terminology: Nifty Pharma Prediction For Tomorrow<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#Conclusion_Nifty_Pharma_Prediction_For_Tomorrow_2_July_2026\" title=\"Conclusion: Nifty Pharma Prediction For Tomorrow 2 July 2026\">Conclusion: Nifty Pharma Prediction For Tomorrow 2 July 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#1_What_is_the_Nifty_Pharma_prediction_for_tomorrow_2_July_2026\" title=\"1. What is the Nifty Pharma prediction for tomorrow 2 July 2026?\">1. What is the Nifty Pharma prediction for tomorrow 2 July 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#2_What_are_the_Nifty_Pharma_support_and_resistance_for_2_July\" title=\"2. What are the Nifty Pharma support and resistance for 2 July?\">2. What are the Nifty Pharma support and resistance for 2 July?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#3_Why_did_Nifty_Pharma_fall_on_1_July_2026\" title=\"3. Why did Nifty Pharma fall on 1 July 2026?\">3. Why did Nifty Pharma fall on 1 July 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#4_Why_is_Cipla_outperforming_in_the_Nifty_Pharma_prediction_for_tomorrow\" title=\"4. Why is Cipla outperforming in the Nifty Pharma prediction for tomorrow?\">4. Why is Cipla outperforming in the Nifty Pharma prediction for tomorrow?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#5_What_is_Dr_Reddys_profit_booking_and_how_does_it_affect_the_Nifty_Pharma_prediction_for_tomorrow\" title=\"5. What is Dr Reddy&#8217;s profit booking and how does it affect the Nifty Pharma prediction for tomorrow?\">5. What is Dr Reddy&#8217;s profit booking and how does it affect the Nifty Pharma prediction for tomorrow?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#6_What_catalyst_would_reverse_the_Nifty_Pharma_prediction_for_tomorrow_bullish\" title=\"6. What catalyst would reverse the Nifty Pharma prediction for tomorrow bullish?\">6. What catalyst would reverse the Nifty Pharma prediction for tomorrow bullish?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#7_What_is_the_GIFT_Nifty_signal_for_the_Nifty_Pharma_prediction_for_tomorrow\" title=\"7. What is the GIFT Nifty signal for the Nifty Pharma prediction for tomorrow?\">7. What is the GIFT Nifty signal for the Nifty Pharma prediction for tomorrow?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-prediction-for-tomorrow-2-july-2026\/#8_What_are_the_key_risks_to_the_Nifty_Pharma_prediction_for_tomorrow_2_July\" title=\"8. What are the key risks to the Nifty Pharma prediction for tomorrow 2 July?\">8. What are the key risks to the Nifty Pharma prediction for tomorrow 2 July?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Market_Recap_Wednesday_1_July_2026\"><\/span><strong>Market Recap: Wednesday 1 July 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Nifty Pharma close:<\/strong> 25,182.70 (-0.57%), range 25,133.25 to 25,591.30. Opened near the week&#8217;s high and sold off, confirming the mild bearish Nifty Pharma prediction for tomorrow bias.<\/li>\n<li><strong>Dr Reddy&#8217;s:<\/strong> Rs 1,357.10 (-1.35%). Post-FDA-approval profit booking after last week&#8217;s sharp FDA-driven rally.<\/li>\n<li><strong>Sun Pharma:<\/strong> Rs 1,862.50 (-0.66%). US specialty pharma pricing concerns and strong rupee reducing export realisation.<\/li>\n<li><strong>Cipla:<\/strong> Rs 1,465.40 (+0.78%). Domestic chronic therapy and respiratory business providing revenue stability independent of US pricing concerns.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Nifty_Pharma_Nifty_Pharma_Prediction_For_Tomorrow_%E2%80%94_Technical_Levels\"><\/span><strong>Nifty Pharma: Nifty Pharma Prediction For Tomorrow \u2014 Technical Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th><strong>Level Type<\/strong><\/th>\n<th><strong>Value<\/strong><\/th>\n<th><strong>Significance<\/strong><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Wednesday Close<\/td>\n<td>25,182.70<\/td>\n<td>Base for<\/td>\n<\/tr>\n<tr>\n<td>Wednesday High<\/td>\n<td>25,591.30<\/td>\n<td>Intraday resistance reference; week&#8217;s high<\/td>\n<\/tr>\n<tr>\n<td>Wednesday Low<\/td>\n<td>25,133.25<\/td>\n<td>Key intraday support reference<\/td>\n<\/tr>\n<tr>\n<td>Support 1<\/td>\n<td>25,100<\/td>\n<td>Must-hold for<\/td>\n<\/tr>\n<tr>\n<td>Support 2<\/td>\n<td>24,900<\/td>\n<td>Strong floor; two-week support zone<\/td>\n<\/tr>\n<tr>\n<td>Support 3<\/td>\n<td>24,700<\/td>\n<td>Critical floor for<\/td>\n<\/tr>\n<tr>\n<td>Resistance 1<\/td>\n<td>25,450<\/td>\n<td>First bull target; below Wednesday high<\/td>\n<\/tr>\n<tr>\n<td>Resistance 2<\/td>\n<td>25,650<\/td>\n<td>Next ceiling; at Wednesday opening range<\/td>\n<\/tr>\n<tr>\n<td>Cipla CMP<\/td>\n<td>Rs 1,465.40 (+0.78%)<\/td>\n<td>Relative strength within<\/td>\n<\/tr>\n<tr>\n<td>Dr Reddy&#8217;s CMP<\/td>\n<td>Rs 1,357.10 (-1.35%)<\/td>\n<td>Post-FDA profit booking; primary drag<\/td>\n<\/tr>\n<tr>\n<td>India VIX<\/td>\n<td>13.24 (-2.65%)<\/td>\n<td>Low fear; pharma weakness is export-specific<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ankit Jaiswal observes that the <strong>Nifty Pharma prediction for tomorrow<\/strong> is experiencing consolidation after the sector&#8217;s strong June FDA-approval-driven rally. He notes that Dr Reddy&#8217;s 1.35% decline reflects post-FDA profit booking \u2014 the stock normalising after a sharp previous-week rally. For the <strong>Nifty Pharma prediction for tomorrow<\/strong> to recover, Sun Pharma needs to hold above Rs 1,840 and Cipla needs to extend its relative strength above Rs 1,480 on Thursday.<\/p>\n<p>Kunal Singla notes that the <strong>Nifty Pharma prediction for tomorrow<\/strong> faces a specific risk from the US generic drug pricing environment. He observes that US FDA approvals drive only the supply side \u2014 if US generic pricing continues compressing, new approvals may not fully translate into revenue upside. Kunal Singla flags 25,100 as the critical support \u2014 sustained hold above this on Thursday signals the correction is shallow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Global_Cues_Affecting_the_Nifty_Pharma_Prediction_For_Tomorrow\"><\/span><strong>Global Cues Affecting the Nifty Pharma Prediction For Tomorrow<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>US Markets:<\/strong> Dow Jones near 52,200 and Nasdaq under pressure from the global IT selloff. Any Nasdaq recovery overnight would meaningfully shift Thursday&#8217;s Indian market sentiment and sector rotation.<\/li>\n<li><strong>US ISM Services PMI (2 July):<\/strong> The first major US data point of Q3 2026. A strong print supports risk-on globally; a miss could trigger Dollar strength and FII selling from Indian equities on Thursday.<\/li>\n<li><strong>US-Iran Doha Talks:<\/strong> US-Iran resumed talks in Doha this week. Stable geopolitical tone keeps crude oil contained below USD 73 per barrel, supporting cost-sensitive sectors and reducing broader market risk.<\/li>\n<li><strong>India VIX:<\/strong> India VIX at 13.24 (-2.65%) on Wednesday, touching a multi-session low of 13.15 intraday. This is a primary constructive signal: low VIX supports cleaner directional price action on Thursday.<\/li>\n<li><strong>GIFT Nifty at 9:00 AM:<\/strong> Check GIFT Nifty on Thursday at 9:00 AM IST. Above 24,050 signals a gap-up Nifty 50 open and a positive bias across all sectors. Below 23,900 signals caution and warrants reduced position size.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_Driving_the_Nifty_Pharma_Prediction_for_Tomorrow\"><\/span><strong>Stocks Driving the Nifty Pharma Prediction for Tomorrow<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Cipla (+0.78%):<\/strong> Cipla at Rs 1,465.40 is Wednesday&#8217;s pharma outperformer. Domestic therapy focus provides revenue stability less exposed to US pricing concerns \u2014 the relative safe haven for the Nifty Pharma prediction for tomorrow.<\/li>\n<li><strong>Sun Pharma (-0.66%):<\/strong> Sun Pharma at Rs 1,862.50 declined mildly. As the sector&#8217;s largest constituent, recovery above Rs 1,870 on Thursday would be a meaningful bullish signal for the Nifty Pharma prediction for tomorrow.<\/li>\n<li><strong>Dr Reddy&#8217;s (-1.35%):<\/strong> Dr Reddy&#8217;s at Rs 1,357.10 saw the largest decline as post-FDA profit booking set in. Stabilisation above Rs 1,340 on Thursday is the key watch level.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Trading_Strategy_for_the_Nifty_Pharma_Prediction_For_Tomorrow\"><\/span><strong>Trading Strategy for the Nifty Pharma Prediction For Tomorrow<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Cipla above Rs 1,470 Thursday extends the relative strength momentum. Entry Rs 1,462-1,472, target Rs 1,492, stop Rs 1,442.<\/li>\n<li>Sun Pharma recovery above Rs 1,870 is the primary large-cap signal for Nifty Pharma prediction for tomorrow improvement. Entry Rs 1,858-1,870, target Rs 1,892, stop Rs 1,835.<\/li>\n<li>Avoid fresh Dr Reddy&#8217;s longs until post-FDA profit booking exhausts. Watch for Rs 1,340 stabilisation support.<\/li>\n<li>The 25,450 resistance is the first confirmation for Nifty Pharma prediction for tomorrow recovery \u2014 a daily close above on Thursday signals the correction has ended.<\/li>\n<li>Monitor any US ANDA approval announcements for Indian pharma companies Thursday \u2014 immediate positive catalysts for the Nifty Pharma prediction for tomorrow.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"F_O_and_Options_Data_for_the_Nifty_Pharma_Prediction_For_Tomorrow\"><\/span><strong>F&amp;O and Options Data for the Nifty Pharma Prediction For Tomorrow<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th><strong>Strike \/ Level<\/strong><\/th>\n<th><strong>Call OI \/ Buy<\/strong><\/th>\n<th><strong>Put OI \/ Sell<\/strong><\/th>\n<th><strong>Significance<\/strong><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>25,650 Call<\/td>\n<td>High OI<\/td>\n<td>Low OI<\/td>\n<td>Extended ceiling for<\/td>\n<\/tr>\n<tr>\n<td>25,450 Call<\/td>\n<td>Moderate OI<\/td>\n<td>Low OI<\/td>\n<td>Near-term resistance; first recovery signal<\/td>\n<\/tr>\n<tr>\n<td>25,200<\/td>\n<td>Moderate OI<\/td>\n<td>Moderate OI<\/td>\n<td>Current pivot for<\/td>\n<\/tr>\n<tr>\n<td>25,100 Put<\/td>\n<td>Low OI<\/td>\n<td>High OI<\/td>\n<td>Must-hold support zone<\/td>\n<\/tr>\n<tr>\n<td>24,900 Put<\/td>\n<td>Very Low OI<\/td>\n<td>Very High OI<\/td>\n<td>Strong floor for<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Nifty Pharma options show Put writing at 24,900-25,100 as the structural floor for the <strong>Nifty Pharma prediction for tomorrow<\/strong>. Call writers at 25,450-25,650 define the ceiling. The positioning suggests measured consolidation between 25,100 and 25,450 through Thursday.<\/p>\n<p><strong>Univest is a SEBI-Registered Investment Advisor \u2013 Get Expert Nifty Pharma Analysis<\/strong><\/p>\n<p>Univest is registered with SEBI as a Research Analyst (INH000013776). All levels in this nifty pharma prediction for tomorrow are for educational reference only \u2014 always verify from official NSE\/BSE\/MCX sources before any investment decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"GIFT_Nifty_Signal_for_Thursday_2_July_2026\"><\/span><strong>GIFT Nifty Signal for Thursday 2 July 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th><strong>GIFT Nifty Level<\/strong><\/th>\n<th><strong>Signal<\/strong><\/th>\n<th><strong>Action<\/strong><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Above 24,050<\/td>\n<td>Gap-up; bullish<\/td>\n<td>All long setups valid; confirm after first 15-min candle<\/td>\n<\/tr>\n<tr>\n<td>24,006 to 24,050<\/td>\n<td>Flat; neutral<\/td>\n<td>Wait for first 15-min candle before entry<\/td>\n<\/tr>\n<tr>\n<td>23,900 to 24,006<\/td>\n<td>Mild gap-down; cautious<\/td>\n<td>Reduce position size 30%; watch 23,900 hold<\/td>\n<\/tr>\n<tr>\n<td>Below 23,900<\/td>\n<td>Gap-down; bearish<\/td>\n<td>Avoid fresh longs; monitor 23,750 as next support<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A GIFT Nifty gap-up Thursday provides mild support for pharma equities through general risk sentiment improvement. Kunal Singla notes the Nifty Pharma prediction for tomorrow is more influenced by US FDA decisions and rupee-dollar dynamics than by domestic GIFT Nifty direction.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_to_Watch_for_the_Nifty_Pharma_Prediction_For_Tomorrow\"><\/span><strong>Stocks to Watch for the Nifty Pharma Prediction For Tomorrow<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th><strong>Stock<\/strong><\/th>\n<th><strong>CMP (1 Jul)<\/strong><\/th>\n<th><strong>Change<\/strong><\/th>\n<th><strong>Watch Level<\/strong><\/th>\n<th><strong>Target<\/strong><\/th>\n<th><strong>Stop Loss<\/strong><\/th>\n<th><strong>Catalyst<\/strong><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Cipla<\/strong><\/td>\n<td>Rs 1,465.40<\/td>\n<td>+0.78%<\/td>\n<td>Rs 1,462\u20131,472<\/td>\n<td>Rs 1,492<\/td>\n<td>Rs 1,442<\/td>\n<td>Wednesday pharma leader; domestic business strength<\/td>\n<\/tr>\n<tr>\n<td><strong>Sun Pharma<\/strong><\/td>\n<td>Rs 1,862.50<\/td>\n<td>-0.66%<\/td>\n<td>Rs 1,858\u20131,873<\/td>\n<td>Rs 1,895<\/td>\n<td>Rs 1,835<\/td>\n<td>Largest pharma cap; recovery above Rs 1,870 key<\/td>\n<\/tr>\n<tr>\n<td><strong>Dr Reddy&#8217;s Laboratories<\/strong><\/td>\n<td>Rs 1,357.10<\/td>\n<td>-1.35%<\/td>\n<td>Rs 1,340\u20131,360<\/td>\n<td>Rs 1,382<\/td>\n<td>Rs 1,325<\/td>\n<td>Post-FDA profit booking; watch Rs 1,340 support<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ankit Jaiswal, Senior Research Analyst at Univest, flags Cipla as the primary relative strength trade in the <strong>Nifty Pharma prediction for tomorrow<\/strong>. Kunal Singla, Associate Director at Univest, highlights Sun Pharma&#8217;s recovery above Rs 1,870 as the most important large-cap signal for Thursday direction. Both analysts advise caution on Dr Reddy&#8217;s until post-FDA profit booking completes. All levels for educational reference only.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Terminology_Nifty_Pharma_Prediction_For_Tomorrow\"><\/span><strong>Key Terminology: Nifty Pharma Prediction For Tomorrow<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Nifty Pharma prediction for tomorrow<\/strong> is also searched as <strong>pharmaceutical sector prediction for tomorrow<\/strong>, <strong>Sun Pharma share price prediction for tomorrow<\/strong>, and <strong>Cipla prediction for 2 July<\/strong>. US FDA approvals and US generic drug pricing are primary factors shaping the <strong>Nifty Pharma prediction for tomorrow<\/strong> as covered by Ankit Jaiswal and Kunal Singla at Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Nifty_Pharma_Prediction_For_Tomorrow_2_July_2026\"><\/span><strong>Conclusion: Nifty Pharma Prediction For Tomorrow 2 July 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Nifty Pharma prediction for tomorrow<\/strong> 2 July 2026 is cautiously bearish at 25,182.70 (-0.57%), reflecting Dr Reddy&#8217;s profit booking (-1.35%) and mild Sun Pharma weakness (-0.66%), partially offset by Cipla&#8217;s relative strength (+0.78%). Support at 25,100 and resistance at 25,450 are the critical levels.<\/p>\n<p>Kunal Singla advises focusing the <strong>Nifty Pharma prediction for tomorrow<\/strong> strategy on Cipla and Sun Pharma. A close above 25,450 on Thursday signals the consolidation phase has ended. Data from NSE and Groww \u2014 verify before trading.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> The securities quoted, if any, are for illustration purposes only and are not recommendatory. This article is for educational purposes only and shall not be considered as investment advice or a recommendation by Univest (Uniresearch Global Pvt Ltd, SEBI Registered Research Analyst INH000013776). Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Data sourced from NSE, BSE, MCX and Groww; verify from official sources before any investment decision.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_What_is_the_Nifty_Pharma_prediction_for_tomorrow_2_July_2026\"><\/span><strong>1. What is the Nifty Pharma prediction for tomorrow 2 July 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nifty Pharma closed at 25,182.70 (-0.57%) on Wednesday. Dr Reddy&#8217;s -1.35%, Sun Pharma -0.66%, Cipla +0.78%. Support 25,100, resistance 25,450. The is cautiously bearish.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_What_are_the_Nifty_Pharma_support_and_resistance_for_2_July\"><\/span><strong>2. What are the Nifty Pharma support and resistance for 2 July?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Support: 25,100 (immediate), 24,900 (strong floor). Resistance: 25,450 (first recovery signal), 25,650 (next ceiling). A close above 25,450 Thursday signals the profit-booking phase has ended.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Why_did_Nifty_Pharma_fall_on_1_July_2026\"><\/span><strong>3. Why did Nifty Pharma fall on 1 July 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nifty Pharma fell 0.57% driven by Dr Reddy&#8217;s post-FDA profit booking (-1.35%) and Sun Pharma&#8217;s US pricing concerns (-0.66%). Cipla&#8217;s +0.78% domestic business resilience partially offset the decline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Why_is_Cipla_outperforming_in_the_Nifty_Pharma_prediction_for_tomorrow\"><\/span><strong>4. Why is Cipla outperforming in the Nifty Pharma prediction for tomorrow?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla&#8217;s domestic chronic therapy and respiratory business generates consistent revenue less exposed to US generic drug pricing fluctuations, creating the relative strength visible in Wednesday&#8217;s setup.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_What_is_Dr_Reddys_profit_booking_and_how_does_it_affect_the_Nifty_Pharma_prediction_for_tomorrow\"><\/span><strong>5. What is Dr Reddy&#8217;s profit booking and how does it affect the Nifty Pharma prediction for tomorrow?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr Reddy&#8217;s had a sharp rally following a recent US FDA approval. The 1.35% Wednesday decline reflects institutional profit-taking at elevated levels \u2014 a normal post-catalyst correction that creates near-term pressure on the .<\/p>\n<h3><span class=\"ez-toc-section\" id=\"6_What_catalyst_would_reverse_the_Nifty_Pharma_prediction_for_tomorrow_bullish\"><\/span><strong>6. What catalyst would reverse the Nifty Pharma prediction for tomorrow bullish?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A new US FDA drug approval for an Indian pharma company, rupee weakening improving export realisation, or a US generic drug pricing policy reversal supporting higher pricing would be the most broadly positive catalysts for the .<\/p>\n<h3><span class=\"ez-toc-section\" id=\"7_What_is_the_GIFT_Nifty_signal_for_the_Nifty_Pharma_prediction_for_tomorrow\"><\/span><strong>7. What is the GIFT Nifty signal for the Nifty Pharma prediction for tomorrow?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A GIFT Nifty above 24,050 provides mild support. However, the is driven more by US FDA regulatory news and rupee-dollar dynamics than domestic equity market direction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"8_What_are_the_key_risks_to_the_Nifty_Pharma_prediction_for_tomorrow_2_July\"><\/span><strong>8. What are the key risks to the Nifty Pharma prediction for tomorrow 2 July?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks: US FDA warning letter to an Indian pharma facility; Sun Pharma or Dr Reddy&#8217;s reporting large-deal losses; US generic price erosion worsening; or broader market sell-off pulling pharma below 25,100 support in the .<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live prices and get daily market predictions on your phone.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nifty Pharma prediction for tomorrow 2 July 2026: Index at 25,182.70 (-0.57%). Dr Reddy&#8217;s -1.35%, Sun Pharma -0.66%. Cipla +0.78% relative strength. Support 25,100, resistance 25,450. Univest.<\/p>\n","protected":false},"author":35,"featured_media":137869,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-137815","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782908158:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["72"],"rank_math_title":["Nifty Pharma Prediction for Tomorrow 2 July 2026: Technical Levels"],"rank_math_description":["Nifty Pharma prediction for tomorrow 2 July 2026: Index at 25,182.70 (-0.57%). Dr Reddy's -1.35%, Sun Pharma -0.66%. Cipla +0.78% relative strength. Support 25,100, resistance 25,450. Univest."],"rank_math_focus_keyword":["Nifty Pharma Prediction for Tomorrow"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["137869"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["22937"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Nifty-Pharma-Prediction-for-Tomorrow.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/137815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=137815"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/137815\/revisions"}],"predecessor-version":[{"id":137870,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/137815\/revisions\/137870"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/137869"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=137815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=137815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=137815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}